Concepedia

Publication | Open Access

Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study

14

Citations

34

References

2021

Year

Abstract

Serum SEMA4C demonstrated promising potential as a candidate biomarker for breast cancer diagnosis. However, validation in prospective settings and by other study groups is warranted.

References

YearCitations

Page 1